Sfoglia per Titolo

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 3.698 a 3.717 di 46.613
Titolo Data di pubblicazione Autore(i) File
Atazanavir/ritonavir monotherapy as maintenance strategy in HIV-1 treated subjects with viral suppression: 96-week analysis results of the MODAT study 1-gen-2014 Spagnuolo, Vincenzo; Galli, Laura; Bigoloni, Alba; Nozza, Silvia; Monforte Antonella, D'Arminio; Antinori, Andrea; Di Biagio, Antonio; Rusconi, Stefano; Guaraldi, Giovanni; Di Giambenedetto, Simona; Lazzarin, Adriano; Castagna, Antonella
Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trial 1-gen-2016 Galli, L; Spagnuolo, V; Bigoloni, A; D'Arminio Monforte, A; Montella, F; Antinori, A; Di Biagio, A; Rusconi, S; Guaraldi, G; Di Giambenedetto, S; Borderi, M; Gibellini, D; Caramatti, G; Lazzarin, A; Castagna, A; on behalf of the MODAt Study, Group; Nozza, Silvia
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 1-gen-2018 Fabbiani, Massimiliano; Gagliardini, Roberta; Ciccarelli, Nicoletta; Quiros Roldan, Eugenia; Latini, Alessandra; D'Ettorre, Gabriella; Antinori, Andrea; Castagna, Antonella; Orofino, Giancarlo; Francisci, Daniela; Chinello, Pierangelo; Madeddu, Giordano; Grima, Pierfrancesco; Rusconi, Stefano; Del Pin, Barbara; Lombardi, Francesca; D'Avino, Alessandro; Focà, Emanuele; Colafigli, Manuela; Cauda, Roberto; Di Giambenedetto, Simona; De Luca, Andrea; on behalf of on behalf of the ATLAS-M Study, Group
Atene e Gerusalemme: una fusione di orizzonti 1-gen-2011 Girgenti, Giuseppe
Atezolizumab and bevacizumab in advanced HCC: ready for prime time? 1-gen-2020 Casadei-Gardini, A; Cascinu, S; Colombo, M
Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma: Ready for Prime Time? 1-gen-2021 Casadei-Gardini, A.; Cascinu, S.; Colombo, M.
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial 1-gen-2017 Balar, Av; Balar, Av; Rosenberg, Je; Powles, T; Petrylak, Dp; Bellmunt, J; Loriot, Y; Necchi, A; Hoffman-Censits, J; Perez-Gracia, Jl; Dawson, Na; van der Heijden, Ms; Dreicer, R; Srinivas, S; Retz, Mm; Joseph, Rw; Drakaki, A; Vaishampayan, Un; Sridhar, Ss; Quinn, Di; Duran, I; Shaffer, Dr; Eigl, Bj; Grivas, Pd; Yu, Ey; Li, S; Kadel, Ee; Boyd, Z; Bourgon, R; Hegde, Ps; Mariathasan, S; Thastrom, A; Abidoye, Oo; Fine, Gd; Bajorin, Df
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial 1-gen-2016 Rosenberg, Je; Hoffman-Censits, J; Powles, T; van der Heijden, Ms; Balar, Av; Necchi, A; Dawson, N; O'Donnell, Ph; Balmanoukian, A; Loriot, Y; Srinivas, S; Retz, Mm; Grivas, P; Joseph, Rw; Galsky, Md; Fleming, Mt; Petrylak, Dp; Perez-Gracia, Jl; Burris, Ha; Castellano, D; Canil, C; Bellmunt, J; Bajorin, D; Nickles, D; Bourgon, R; Frampton, Gm; Cui, N; Mariathasan, S; Abidoye, O; Fine, Gd; Dreicer, R
Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Outcomes by Prior Number of Regimens 1-gen-2018 Perez-Gracia, Jl; Loriot, Y; Rosenberg, Je; Powles, T; Necchi, A; Hussain, Sa; Morales-Barrera, R; Retz, Mm; Niegisch, G; Duran, I; Theodore, C; Grande, E; Shen, Xd; Wang, Jj; Nelson, B; Derleth, Cl; van der Heijden, Ms
Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: post-progression outcomes from the phase II IMvigor210 study 1-gen-2017 Necchi, A; Joseph, Rw; Loriot, Y; Hoffman-Censits, J; Perez-Gracia, Jl; Petrylak, Dp; Derleth, Cl; Tayama, D; Zhu, Q; Ding, B; Kaiser, C; Rosenberg, Je
Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population 1-gen-2022 Casadei-Gardini, Andrea; Rimini, Margherita; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Rimassa, Lorenza; Presa, José; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Tovoli, Francesco; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; Himmelsbach, Vera; Pressiani, Tiziana; Montes, Margarida; Vivaldi, Caterina; Soldà, Caterina; Piscaglia, Fabio; Hiraoka, Atsushi; Sho, Takuya; Niizeki, Takashi; Nishida, Naoshi; Steup, Christoph; Iavarone, Massimo; Di Costanzo, Giovanni; Marra, Fabio; Scartozzi, Mario; Tamburini, Emiliano; Cabibbo, Giuseppe; Foschi, Francesco Giuseppe; Silletta, Marianna; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Shimada, Noritomo; Kawata, Kazuhito; Tada, Fujimasa; Ohama, Hideko; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Kosaka, Hisashi; Naganuma, Atsushi; Koizumi, Yohei; Nakamura, Shinichiro; Kaibori, Masaki; Iijima, Hiroko; Hiasa, Yoichi; Burgio, Valentina; Persano, Mara; Della Corte, Angelo; Ratti, Francesca; De Cobelli, Francesco; Aldrighetti, Luca; Cascinu, Stefano; Cucchetti, Alessandro
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis 1-gen-2022 Rimini, M; Rimassa, L; Ueshima, K; Burgio, V; Shigeo, S; Tada, T; Suda, G; Yoo, C; Cheon, J; Pinato, D J; Lonardi, S; Scartozzi, M; Iavarone, M; Di Costanzo, G G; Marra, F; Soldà, C; Tamburini, E; Piscaglia, F; Masi, G; Cabibbo, G; Foschi, F G; Silletta, M; Pressiani, T; Nishida, N; Iwamoto, H; Sakamoto, N; Ryoo, B-Y; Chon, H J; Claudia, F; Niizeki, T; Sho, T; Kang, B; D'Alessio, A; Kumada, T; Hiraoka, A; Hirooka, M; Kariyama, K; Tani, J; Atsukawa, M; Takaguchi, K; Itobayashi, E; Fukunishi, S; Tsuji, K; Ishikawa, T; Tajiri, K; Ochi, H; Yasuda, S; Toyoda, H; Ogawa, C; Nishimur, T; Hatanaka, T; Kakizaki, S; Shimada, N; Kawata, K; Tanaka, T; Ohama, H; Nouso, K; Morishita, A; Tsutsui, A; Nagano, T; Itokawa, N; Okubo, T; Arai, T; Imai, M; Naganuma, A; Koizumi, Y; Nakamura, S; Joko, K; Iijima, H; Hiasa, Y; Pedica, F; De Cobelli, F; Ratti, F; Alrighetti, L; Kudo, M; Cascinu, S; Casadei-Gardini, A
Atherosclerosis and inflammatory bowel disease: Sharing a common pathogenic pathway? 1-gen-2003 Danese, S; Fiocchi, C
Atherosclerosis: a classic inflammatory disease 1-gen-2011 Antonia, Anogeianaki; Domenico, Angelucci; Ettore, Cianchetti; Margherita, D'Alessandro; Giulio, Maccauro; Andrea, Saggini; Salini, Vincenzo; Auro, Caraffa; Tete, Stefano; Conti, Fiorella; Domenico, Tripodi
The atherosclerotic cardiovascular disease risk score is a reliable tool to identify patients with arteriogenic erectile dysfunction 1-gen-2023 Bertini, Alessandro; Pozzi, Edoardo; Fallara, Giuseppe; Lanzaro, Francesco; Candela, Luigi; Costa, Antonio; Corsini, Christian; Cilio, Simone; Belladelli, Federico; Capogrosso, Paolo; D'Arma, Alessia; Montorsi, Francesco; Salonia, Andrea
Athletes’ rest-activity circadian rhythm differs in accordance with the sport discipline 1-gen-2019 Vitale, Jacopo Antonino; Banfi, Giuseppe; Sias, Marco; La Torre, Antonio
Atlante di chirurgia ginecologica conservativa; tecniche tradizionali ed endoscopiche a confronto 1-gen-1999 Candiani, Gb; Candiani, Massimo
Atlante di Chirurgia Laparoscopica in Ginecologia 1-gen-1997 Candiani, Massimo; Canis, M; Luciano, A; Marana, R; Mencaglia, L; Wattiez, A; Zupi, E.
Atlante di Terapia Fotodinamica 1-gen-2002 Battaglia Parodi, M; Saviano, S; Ravalico, G.
Atlanto-occipital dislocation due to aneurysmal bone cyst of the occipital condyle 1-gen-2016 Spina, Alfio; Boari, Nicola; Gagliardi, Filippo; Giudice, Lodoviga; Mortini, Pietro
Mostrati risultati da 3.698 a 3.717 di 46.613
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile